Cryptococcus neoformans is an opportunistic fungal pathogen which preferentially localizes to the inositol-rich environment of the central nervous system. One of its distinguishing traits is its capacity to catabolize inositol. lnositol is a precursor for the synthesis of phosphatidylinositol (PI). This study demonstrated that C. neoformans synthesizes inositol. Three inositolcontaining sphingolipids were identified in C. neofomans : ceramide-(P-inositol),mannose, ceramide-P-inositol-mannose, and ceramide-P-inositol. These inositol-containing sphingolipids are typical of fungi but not higher eukaryotes. The effect of inositol on the membrane lipid composition of C. neoformans was also examined. In contrast to the nonpathogenic yeast Sacchammyces cerevisiae, neither the PI composition nor the synthesis of methylated phospholipids was altered by exogenous inositol. Hence, C. neoformans appears to have a metabolic mechanism for maintaining a steady lipid composition regardless of the inositol in its environment.
INTRODUCTION
Cr_yptococctls neoformans is an opportunistic fungal pathogen that infects humans. It is present but harmless in the respiratory tract of many healthy individuals (Randhawa & Paliwal, 1979) . Infections in immunocompromised individuals usually manifest as meningoencephalitis (Kwon-Chung & Bennett, 1992) . Localization of this organism to the inositol-rich environment of the central nervous system (CNS) (Spector & Lorenzo, 1975) differs from systemic infections with the fungal pathogens Candida albicans (Odds, 1987) and AsPergilhs spp. (Musial et al., 1988) .
Studies of C. neoformans have bcen stimulated by increasing numbers of cryptococcal infections ) and a lack of effective antifungal therapies (Clark e t al., 1990) . Four biological characteristics have been implicated in the pathogenicity of C. neoformans: (1) polysaccharide capsule (Bulmer e t al., 1967; Dykstra e t al., 1977; Fromtling e t al., 1982;  Abbreviations: CNS, central nervous system; DAG, diacylglycerol; IPC, ceramide-P-inositol; MIPC, ceramide-P-inositol-mannose; M(IP),C, ceramide-(P-inositol),mannose; N-MTF, N-methyltransferase; PC, phosphatidylcholine; PDME, phosphatidyldimethylethanolamine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; PMME, phosphatidylmonomethylethanolamine; PSI phojphatidylserine; SAM, 5adenosylmethionine. Jacobson e t al., 1982; Kozel & Cazin, 1971 ; Kozel & Mastroianni, 1976 ; Kozel, 1977 ;  Kwon-Chung & Rhodes, 1986) ; (2) phenoloxidase activity (Jacobson & Emery, 1991 ; Kwon-Chung e t al., 1982; Kwon-Chung & Rhodes, 1986; Polacheck e t al., 1982 Polacheck e t al., , 1990 Rhodes et al., 1982; Wang & Casadevall, 1994) ; (3) ability to grow at 37 "C (Kwon-Chung & Rhodes, 1986; Rhodes et al., 1982) ; and (4) a mating type (Kwon-Chung & Bennett, 1978; Kwon-Chung etal., 1992; Moore & Edman, 1993) . Further identification of unique biochemical and genetic characteristics of this organism may aid in the development of new antifungal treatments. C. neoformans has the distinctive ability to use inositol as a sole carbon source (Barnett, 1976) . This trait has been used clinically for a number of years to identify cryptococcal infections (Konemane & Roberts, 1985) . Inositol is a six-carbon sugar and a precursor for the synthesis of phosphatidylinositol (PI), a major membrane phospholipid (Hokin & Hokin, 1953; Paulus & Kennedy, 1960) . PI is an essential structural component of membranes (Hill e t al., 1990) and is also an anchor for certain membrane proteins (Cross, 1990) . Moreover, PI and its phosphorylated metabolites are integral parts of the signal transduction pathway essential for balanced cellular growth (Berridge & Irvine, 1984) . PI is also the precursor for the synthesis of ceramide-(P-inositol),mannose [M(IP),C], ceramide-P-inositol-mannose (MIPC) and ceramide-P-inositol (IPC), three inositol-containing sphingolipids identified and characterized in Saccbaromyces cerevisiae (Smith & Lester, 1974; Steiner & Lester, 1972; Steiner et al., 1969) .
Inositol-containing sphingolipids have not been observed in higher eukaryotes, however, other sphingolipids and their degradation products have been shown to affect cellular differentiation and proliferation in mammalian cells (Olivera et al., 1992) . In yeast, inability to synthesize sphingolipids results in increased cell density, loss of ability to divide and ultimately loss of viability (Buede et al., 1991 ; Dickson e t al., 1990; Pinto et al., 1992) .
The phospholipid biosynthetic pathway ( Fig. 1 ) and its regulation have been studied in the nonpathogenic yeast S. cerevisiae and in the pathogenic yeast C. albicans (Carman & Henry, 1989) . The presence of exogenous inositol in the growth medium of S. cerevisiae and C. albicans shifts phospholipid biosynthesis toward the formation of PI at the expense of methylated phospholipid synthesis (Bailis et al., 1987; Kelley et al., 1988; Klig e t al., 1985; Poole et al., 1986) . Both S. cerevisiae and C. albicans are capable of phosphatidylcholine (PC) synthesis by two pathways : de novo PC synthesis via methylation of phosphatidylethanolamine (PE) (Klig et al., 1990; Steiner & Lester, 1972) or reaction of CDP-activated choline with diacylglycerol (DAG) (Kennedy & Weiss, 1956; Klig et al., 1990) . In C. albicans, the addition of exogenous choline decreases the synthesis of PC by reducing the activity of the N-methyltransferases (N-MTFs) (Klig e t a!., 1990) . In S. cerevisiae, N-MTF activity decreases in response to choline only if inositol is present (Klig e t al., 1988; Waechter & Lester, 1973; Yamashita e t al., 1982) .
Prior research has established the overall lipid composition of C. neoformans at various growth phases in complex media (Itoh et al., 1975; Itoh & Kaneko, 1977) . This study examined the effects of exogenous inositol on growth, lipid synthesis and lipid composition of C. neoformans. Inositol biosynthesis by C. neoformans is demonstrated. Furthermore, C. neoformans membrane phospholipid composition is shown to be unaltered by the availability of inositol. These data suggest that C. neoformans utilizes a novel regulatory mechanism for inositol metabolism in a programme of balanced cell growth.
METHODS

Strains and media.
All experiments were performed with two serotype D strains of Cr_yptococc~s neoformans, C20a and C21a, obtained from Dr J. Edman at the University of California, San Francisco, USA. Saccharomyes cerevisiae strain A6 (ade6 a) was used as a control.
All strains were maintained on YEPD (1 %, w/v, yeast extract, 2%, w/v, Difco bacto-peptone, 2%, w/v, glucose, 2%, w/v, agar) plates. For experimental procedures, strains were grown in complete synthetic defined (SD) medium (lacking inositol) as described previously (Klig et al., 1990) . SD medium was supplemented with 75 pM inositol as indicated. In SD-inositol medium, 110 mM inositol was substituted for glucose as the carbon source. Where indicated in the text, the media were supplemented with 10 mM choline.
Determination of growth parameters. The growth rate of each yeast strain was determined in SD medium with and without inositol and/or choline supplementation, and in SDinositol medium with and without choline supplementation. Cultures (10 ml) were inoculated and grown overnight at 30 O C with shaking. Cultures were diluted with fresh medium to an OD,,, of 0 1 ( N 10' cells ml-'). The cells were then incubated, shaking, at 30 OC and aliquots were removed at the times indicated. Cell numbers were determined spectrophotometrically (OD,,,) and by viability plating.
Pulse labelling to examine lipid synthesis. Strains C20a, C21a and A6 were grown at 30 OC to mid-exponential phase. The cultures were diluted to 3-5 x lo6 cells ml-'. Incubation at 30 OC was continued until growth resumed and the cells underwent at least one doubling. The cells were then pulse labelled for 15 min with 0 1 mCi 32P ml-' (3.7 MBq 32P ml-l) (8500-9120 mCi mmol-'; NEN/Dupont) or for 30 min with 0.5 pCi [meth_yl-14C]met~onine ml-'
(1 8.5 kBq [meth_l-'4C]methionine ml-') (43-4 mCi mmol-' ; NEN/Dupont) or 1.0 pCi [14C]choline ml-' (37 kBq [14C]choline ml-') (55 mCi mmol-'; ICN).
Steady state in wiwo labelling to examine lipid composition.
Strains C20a, C21a and A6 were grown in the media indicated at 30 OC. The cultures were diluted with fresh media and grown for five to six generations, to mid-exponential phase, in the presence of 0.01 mCi 32P ml-' (0-37 MBq 32P ml-') (8500-9120 mCi mmol-l; NEN/Dupont).
Phospholipid and sphingolipid extraction and separation.
The yeast cells were broken and the lipids extracted essentially as described by Atkinson (1984) . The samples were dried under a stream of nitrogen gas, resuspended in 40 p1 chloroform/ methanol (2:1, v/v), and spotted on Whatman SG81 silicaimpregnanted paper (dipped in 2 %, w/v, EDTA, pH 7.1). The lipids were separated by two-dimensional chromatography. Solvent I for phospholipid separation contained : 198 ml chloroform, 81 ml methanol, 12.5 ml 28.8% (w/v) ammonium hydroxide and 0.6 ml 5 % (w/v) butylated hydroxytoluene in chloroform. Solvent I1 contained : 192 ml chloroform, 24 ml methanol, 6 ml water, 30 ml glacial acetic acid, and 0.6 ml 5 % (w/v) butylated hydroxytoluene in chloroform. For sphingolipid separation, solvent I contained : 135 ml chloro-IP: 54.70.40.11
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Phospholipid biosynthesis in C. neoformans form, 105 ml methanol, 15 ml water, 10 ml 28.8 % (w/v) ammonium hydroxide, and 0.6 ml 5 YO (w/v) butylated hydroxytoluene in chloroform. Solvent I1 contained: 150 ml chloroform, 61 ml methanol, 40 ml glacial acetic acid, 16 ml water, and 0.54 ml 5 YO (w/v) butylated hydroxytoluene in chloroform. 14C-labelled methylated lipids were separated by one-dimensional chromatography. The solvent consisted of chloroform/methanol/28-8 % (w/v) ammonium hydroxide (66:17:3, by vol.).
Autoradiographs, obtained by exposing the chromatograms to Kodak AR-5 X-ray film, were used to locate the labelled lipids. Lipids were identified by their migration patterns relative to standards. The samples were cut from the chromatograms and counted by liquid scintillation. lnositol excretion assay. C20a or C21a was grown on SDinositol medium for up to 1 week. Cells were then transferred to complete SD plates (lacking inositol), sprayed with S. cerevisiae indicator strain AID (ade-llade-I , inol-13/hoL-13, Cys-2/ + , (Greenberg et al., 1982) and incubated at 30 OC.
Growth of the indicator strain, which produces red colonies in the presence of inositol, was evaluated.
Analysis of data. c.p.m. incorporated into each lipid was determined. The percentage of each lipid relative to the total amount of label incorporated in all lipids was then calculated. The mean one standard error of the mean for all experimental trials was determined. One-way or two-way analysis of variance was used to determine the significance of the effects of the precursors on phospholipid synthesis or composition.
RESULTS
Growth parameters of C. neoformans
Two C. neoformans strains, C20a and C21a, and S. cerevisiae strain A6, were grown at 30 "C in SD medium with or without inositol supplementation and in SD-inositol medium without glucose. The doubling times for C. neoformans strains C20a and C21a in SD medium with or without inositol supplementation (75 pM) were approximately 3 h (Table 1) . Both strains entered stationary phase at approximately 3 x lo'cells ml-' in SD 3  3  3  3  3  3  3  3  8   12   3  3  3 3 8 12 medium regardless of inositol supplementation. The growth rates were not altered by the addition of choline to the growth media. In SD-inositol medium (no glucose) the doubling times of both strains of C. neoformans were approximately 8 h, and there were approximately 2 x lo' cells ml-' at stationary phase. When choline was added to SD-inositol medium, the growth rate of both C. neoformans strains was drastically decreased, to a doubling time of approximately 12 h. Similar to C. neoformans, S. cerevisiae strain A6 doubled approximately once every 3 h in SD medium with or without inositol supplementation (75 pM). However, S. cerevisiae did not grow in SDinositol medium without glucose.
Phospholipid synthesis by C. neoformans C. neoformans strains C20a and C21a synthesized typically eukaryotic phospholipids. Both strains synthesized the four major phospholipids PI, PS, PC and PE (Table 2) . Trace amounts of the methylated phospholipids PMME and PDME were also synthesized. Pulse labelling with 32P for 15 min demonstrated the synthesis of PI by strains C20a and C21a regardless of the inositol concentration in the growth medium (Table 2 ). In C. neoformans strain C20a, PI accounted for approximately 30% of the total phospholipids synthesized during a period of 15 min. There was not a statistically significant difference in the phospholipids synthesized in strain C20a regardless of whether inositol was absent from the growth medium, present in micromolar amounts, or provided in millimolar amounts as the sole energy source (PI, P = 0.077; PS, P = 0411; PC, P = 0.257; PE, P = 0.472). In strain C21a, inositol provided as the sole carbon source to media lacking glucose had a slight but statistically significant effect on the synthesis of PI ( P = 0.013) and PS ( P = 0012). In contrast, in S. cerevisiae micromolar amounts of inositol added to media with glucose as a carbon source had a drastic effect on the synthesis of PI ( P < O.OOOl), PC ( P = 0.001) and PE ( P = 0.003). PI represented 27.6 YO of the phospholipids synthesized in 15 min by S. cerevisiae grown in medium without inositol supplementation, whereas in growth medium containing 75 pM inositol PI accounted for 51.6 YO of the phospholipids synthesized.
Phospholipid composition of C. neoformans
To examine the effect of inositol on the phospholipid composition of C. neoformans, cultures were steady-state labelled with 32P for five to six generations (Fig. 2) . The PI percentage of total membrane phospholipids was not altered by exogenous inositol in either strain C20a or C2la (Table 3) . Even when inositol was provided as the sole cabon source, PI remained approximately 8 % of the total phospholipids labelled. The percentage of PI in the membranes of C. neoformans was similar to that of S. cerevisiae grown without inositol. In C. neoformans, the methylated phospholipid pathway which results in the synthesis of PC was also relatively unaltered by exogenous inositol, although some fluctuation is noted in strain C21a incorporated into PC by 1.45 and 2.45 x lo7 cells of strains C20a and C21 a, respectively. The total 14C incorporation into PC was not altered by the presence of inositol.
Methylated phospholipid synthesis by C. neoformans
To examine the effects of inositol and choline on N-MTF activity in C. neoformans, pulse labelling experiments with [meth_yl-14C]methionine were performed (Fig. 3) .
[metlyyl-14C]Methionine can be taken up by cells and converted to [14C]S-adenosylmethionine (SAM). The ["C] SAM can provide the methyl group for the synthesis of PMME, PDME and PC. The relative proportions of 14C-labelled PMME, PDME and PC synthesized by C20a and C21a were not significantly altered by the presence or absence of inositol in the growth medium (Table 4 ). Addition of choline to the growth media, however, resulted in a statistically significant decrease in the proportion of PC (C20a, P < 0.0001; C21a, P = 0.018) and an increase in the proportion of PMME (C20a, P < 0.0001; C21a, P < 0.024). Inositol did not have a significant effect on methylated lipid synthesis in C. neoformans. In S. cerevisiae, choline significantly decreased PC ( P < 0.0001) and increased PMME ( P < 0.0001) synthesis. The addition of both inositol and choline to the growth medium of s, cerevisiae further decreased the proportion of pc (' = 0'003) and increased the proportion Of PMME (P < 0.0001) and PDME ( P < 0.0001). decrease in the proportion of PC ( P = 0*005) in S. cerevisiae strain A6.
PC synthesis by C. neoformans C. neoformans cells were pulse labelled with [14C]choline to establish the existence of an auxiliary pathway for the synthesis of PC. This pathway was originally described in S. cerevisiae (Kennedy & Weiss, 1956 Phospholipid biosynthesis in C. neoformans (lane 7, C2Oa) . Abbreviations: 0, origin; NL, neutral lipids.
Inositol-phosphate-containing sphingolipids in C. neoformans
The presence of inositol-phosphate-containing sphingolipids in C. neoformans was established by steady-state labelling of the lipids with 32P. 32P-labelled lipids extracted from C. neoformans were identified by their migration relative to the standards IPC, MIPC and M(IP),C (Fig. 4) .
These three inositol-containing sphingolipids were found in the membranes of C. neoformans regardless of inositol IP: 54.70.40.11
On: Sat, 15 Dec 2018 00:50:02 V. L. V I N C E N T a n d L. S . K L I G Fig. 4 . Inositol-phosphate-containing sphingolipid composition. Autoradiogram of a two-dimensional chromatographic separation of 32P steady-state labelled sphingolipids from strain C21a grown in SD-inositol medium.
supplementation of the growth medium (Table 6) . Growth of C. neoformans in SD-inositol medium (no glucose), however, led to a decrease in the amount of label incorporated into the inositol-containing sphingolipids.
lnositol excretion assay
To determine if the phospholipid composition was regulated independently of exogenous inositol due to excretion of internal inositol, strains C20a and C21a were tested for inositol excretion. An S. cerevisiae strain AID Phospholipid biosynthesis in C. neoformans 
DISCUSSION
Inositol is a key cellular metabolite which can be used by C. neoformans for the synthesis of membrane lipids and as an energy source for growth. This study examined the effects of exogenous inositol and choline on cell growth, lipid synthesis and lipid composition in two wild-type strains of C. neoformans, C20a and C21a. Both a and a mating type strains grew at similar rates in SD medium with or without inositol and/or choline supplementation (Table 1) . However, the growth rate decreases approximately twofold in SD-inositol medium (without glucose). The growth rate is further decreased by the presence of choline in this medium. C. neoformans was demonstrated to synthesize typically eukaryotic phospholipids by pulse labelling experiments with 32P, [metkyl-14C]methionine and [14C]choline (Tables 2 and 4) . These experiments also showed that PC synthesis occurs via both the de nouo and auxiliary pathways (Fig. 1) . Most importantly, the PI percentage of total phospholipid synthesized is relatively unaffected by the concentration of exogenous inositol in the growth medium. Steadystate labelling experiments revealed that the major phospholipids in the membranes of C. neoformans are PI, PS, PE and PC (Table 3 ). C. neoformans was shown to have the inositol-containing sphingolipids IPC, MIPC and M(IP),C which are unique to yeast. The phospholipid composition data are in agreement with previous studies of C. neoformans lipids which were performed using complex growth medium (Itoh et al., 1975; Itoh 8z Kaneko, 1977) . Another report on the lipid composition of C. neoformans was unable to identify PS or sphingolipids (Rawat et al., 1984) . This discrepancy may be due to dfferences in the extraction and/or separation techniques used for each study. The phospholipid composition analyses presented here indicate that exogenous inositol does not affect the proportion of inositol-containing phospholipids in the membranes of C. neoformans. This study establishes that C. neoformans synthesizes inositol de novo. Specifically, pulse labelling experiments confirm that PI was synthesized in the membranes of cells grown for many generations in medium without inositol. Even though inositol prototrophy is typical of most eukaryotic cells, some fungi are natural inositol auxotrophs (Fernandez e t a/., 1986) . Interestingly, C. neoformans is one of a few yeasts that use inositol as a carbon source (Barnett, 1976) . Thus, this organism can serve as a model to study the coordination of inositol synthesis, uptake and catabolism.
C. neoformans, unlike most other yeasts, has the ability to grow on SD-inositol medium without glucose (Barnett, 1976) . When choline is added to this medium, however, the cells' growth rate decreases. In contrast, choline does not affect the growth rate of C. neoformans in SD media with glucose as an energy source. Choline may be interfering with inositol uptake, inositol catabolism or lipid synthesis.
The addition of inositol and choline to the growth medium of S. cerevisiae alters the proportion of methylated lipids synthesized and decreases total N-MTF activity (Tables 3 and 4 ). The addition of choline with or without inositol to the growth medium of C. albicans alters the proportions of the methylated lipids and decreases N -MTF activity (Klig et al., 1990) . Micromolar amounts of exogenous inositol in the growth medium of C. neoformans do not alter the relative proportion of the methylated phospholipids synthesized (Table 4 ) or the total amount of N-MTF activity ( Table 5 ). The apparent decrease in total c.p.m. incorporation into methylated lipids when the cells are grown in SD-inositol medium is probably due to the decreased growth rate. Addition of choline only slightly alters the proportions of methylated lipids synthesized (Table 4 ) ; however, total N-MTF activity is decreased ( Table 5) . Thus, N-MTF activity in C. neoformans appears to respond to choline and is unaffected by inositol.
PI synthesis by C. neoformans strain C20a is not altered by exogenous inositol in the medium (Table 2) . Strain C21a demonstrated a slight increase in PI synthesis when inositol was provided as the sole carbon source (in millimolar amounts). Supplementation of the growth medium of strain C21a with micromolar amounts of inositol, however, does not result in a significant change in PI synthesis. In contrast, there is a dramatic increase in PI synthesis in S. cereuisiae when the growth medium is supplemented with even micromolar amounts of inositol. Steady-state lipid labelling experiments demonstrated that the overall phospholipid composition of both strains of C. neoformans is not affected by inositol, even when it is provided as the carbon source (Table 3 ). In contrast, the PI percentage of total membrane lipids in S. cereuisiae and C. albicans varies with inositol supplementation of the media (Culbertson et al., 1976; Klig e t al., 1990) . These data suggest that C. neoformans may possess a novel regulatory mechanism for stabilizing its membrane composition.
Three models offer possible mechanisms of a steady C. neoformans phospholipid composition despite variable IP: 54.70.40.11
On: Sat, 15 Dec 2018 00:50:02 V. L. V I N C E N T a n d L. S . KLIG environments. The first model proposes that de nouo inositol synthesis results in an internal inositol concentration sufficient to fully saturate PI synthase. Addition of inositol to the growth media would have no effect on the already saturated PI synthase. The second model also involves de novo inositol synthesis, proposing that the internal inositol concentration is consistently sufficient to repress the N-MTFs. CDP-DAG is the common precursor for the synthesis of PI and the methylated phospholipids. Maintenance of repressed N-MTFs would result in a steady amount of CDP-DAG available for PI synthesis. Addition of inositol to the growth media would, again, have no effect on the already repressed N-MTFs resulting in a steady phospholipid composition. The third model proposes that C. neoformans maintains a constant internal inositol concentration. This pool size is not necessarily at saturating or repressing levels. This study suggests that the intracellular inositol concentration does not appear to be regulated by excretion. However, the internal inositol pool size could be controlled by regulating either inositol uptake or catabolism. A constant internal pool of inositol, regardless of inositol availability, would result in a steady phospholipid composition.
C. neoformans is surrounded by a polysaccharide capsule which has been shown to decrease the phagocytosis of C. neoformans by leukocytes (Kozel & Cazin, 1971 ; Kozel & Mastroianni, 1976 ; Kozel, 1977) . The capsule is composed of a mannose backbone with xylose and glucuronic acid side chains (Bhattacharjee e t a/., 1979). In plants, inositol is a precursor of glucuronic acid and xylose (Moore & Edman, 1993) . It is interesting to speculate that in C. neoformans inositol catabolic products may be used for capsule synthesis.
Cryptococcal infections in immunocompromised individuals preferentially localized to the CNS where the concentration of inositol is high (Spector, 1976 ; Spector & Lorenzo, 1975) . Two unusual traits of C. neoformans are the utilization of inositol as a carbon source and maintenance of a constant PI percentage in its membranes. These traits may influence its localization to the inositolrich environment of the CNS.
